Professor of Molecular and Digital Pathology, Kings College Hospital
Professor Anita Grigoriadis is a leading expert in Molecular and Digital Pathology at King’s College London, where she heads the Cancer Bioinformatics teams, the Spatial Biology Facility, and serves as an Executive Committee Member and Training Lead at the CRUK City of London Centre.
Anita’s research combines AI-driven molecular and digital pathology approaches to identify features in normal breast tissue, primary tumour lesions, and nearby lymph nodes of breast cancer patients that are associated with early signs of cancer and disease progression.
Recently Anita has received £18.9 million in funding from the UK government’s Research Ventures Catalyst (RVC) programme, to establish PharosAI. This funding adds to £24.7 million raised from partners including charities, pharma, biotech and technology companies, and public research organisations. PharosAI’s goal is to be a catalyst for AI models in health research and health care, and how this work can help set the standards for frameworks, platforms, tools, and policies to enable AI/ML models in a safe and ethically appropriate manner.
What is Lorem Ipsum?
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.